Guselkumab Provides Durable Improvement Across Psoriatic Arthritis Disease Domains: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo Controlled Study
COATES LC., Gossec L., Zimmermann M., Shawi M., Rampakakis E., Shiff NJ., Kollmeier AP., Xu XL., Nash P., Mease PJ., Helliwell PS.